McKinley Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
McKinley Capital Management's GILD Position: Q2 2018 in Review
McKinley Capital Management sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 2,130 shares — an estimated $161K sold.
McKinley Capital Management first reported a position in GILD in Q2 2013 and held it in 20 quarters. The position peaked at $69.4M in Q4 2013. 1,522 funds tracked by Wall St. Rank hold GILD as of Q2 2018.
- McKinley Capital Management reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
- McKinley Capital Management sold 2,130 Gilead Sciences shares in Q2 2018, an estimated $161K.
- McKinley Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 20 quarters.
- McKinley Capital Management's Gilead Sciences position peaked at $69.4M in Q4 2013.
- 1,522 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.
Based on McKinley Capital Management's 13F filing for Q2 2018, filed 13 Jul 2018.